Long Zi-Wen, Zhou Meng-Long, Fu Jing-Wei, Chu Xian-Qun, Wang Ya-Nong
Zi-Wen Long, Meng-Long Zhou, Ya-Nong Wang, Department of Gastric Cancer and Soft-tissue Sarcoma Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China.
World J Gastroenterol. 2015 Mar 28;21(12):3694-705. doi: 10.3748/wjg.v21.i12.3694.
To construct a meta-analysis in order to examine the relationship between cadherin-17 (CDH17) and gastric cancer (GC).
Related articles were selected by searching the following English or Chinese electronic databases: CINAHL, MEDLINE, Science Citation Index, the Chinese Journal Full-Text, and the Weipu Journal. Newcastle-Ottawa Scale (NOS) criteria were used to ensure consistency in reviewing and reporting results. Statistical analyses were conducted with Version 12.0 STATA statistical software.
Ultimately, 11 articles, with a total of 2,120 GC patients, were found to be eligible for study inclusion. In comparisons of GC patients by TNM stage (III-IV vs I-II: OR = 2.35, 95%CI: 1.15-4.825, P = 0.019), histologic grade (3-4 vs 1-2: OR = 3.48, 95%CI: 1.36-8.92, P = 0.009), invasion grade (T3-4 vs T1-2: OR = 2.86; 95%CI: 1.69-4.83; P = 0.000), and lymph node metastasis (positive vs negative: OR = 2.64; 95%CI: 1.33-5.27; P = 0.006), it was found that CDH17 showed more positive expressions in each of the more severe cases. Country-stratified analyses from all four experimental subgroups showed that high CDH17 expression levels may be related to GC among Chinese and Korean populations (all P < 0.05), with the exception of the invasion grade T3-4 vs T1-2 comparison, where the relation only held among the Chinese population (OR = 2.86, 95%CI: 1.69-4.83, P = 0.000).
Collectively, the data reflects the capacity of CDH17 in tumor proliferation and metastasis among GC patients.
构建一项荟萃分析,以研究钙黏蛋白-17(CDH17)与胃癌(GC)之间的关系。
通过检索以下英文或中文电子数据库来选择相关文章:CINAHL、MEDLINE、科学引文索引、中国期刊全文数据库和维普期刊。采用纽卡斯尔-渥太华量表(NOS)标准来确保结果审查和报告的一致性。使用STATA 12.0统计软件进行统计分析。
最终,共发现11篇文章,涉及2120例GC患者,符合纳入研究标准。在按TNM分期(III-IV期与I-II期比较:OR = 2.35,95%CI:1.15 - 4.825,P = 0.019)、组织学分级(3 - 4级与1 - 2级比较:OR = 3.48,95%CI:1.36 - 8.92,P = 0.009)、浸润分级(T3 - 4期与T1 - 2期比较:OR = 2.86;95%CI:1.69 - 4.83;P = 0.000)以及淋巴结转移(阳性与阴性比较:OR = 2.64;95%CI:1.33 - 5.27;P = 0.006)对GC患者进行比较时,发现CDH17在每种更严重的病例中均表现出更多的阳性表达。来自所有四个实验亚组的国家分层分析表明,在中国和韩国人群中,CDH17高表达水平可能与GC有关(所有P < 0.05),浸润分级T3 - 4期与T1 - 2期比较除外,该关系仅在中国人群中成立(OR = 2.86,95%CI:¹.69¬ - 4.83,P = 0.000)。
总体而言,数据反映了CDH17在GC患者肿瘤增殖和转移中的作用。